Market attention is now turning to the Fed's two-day policy meeting, which kicks off on Tuesday, with the focus on what the central bank has to say about those tariff risks to the economy.
Risks are growing that the Federal Reserve could end up delivering either fewer or more rate cuts in 2025 than many people expect, according to Scott Buchta, head of fixed-income strategy for Brean ...
Investors are optimistic that the company can overcome its difficulties following last year’s 40% drop in its stock price, which was mainly due..
Wondering where Apple stock may be in five years? Learn what the current state of AAPL stock is and what its five year ...
Beyond, Inc. is in a transition phase, rebranding under Bed Bath & Beyond, and aims to streamline SKUs to improve profitability amid a competitive market.
Nasdaq 100 and S&P 500 face selling pressure as recession fears rise. Fed’s rate outlook and weak housing data weigh on investor sentiment.
Micron Technology's recent guidance was disappointing. Read more to see why I downgrade MU stock from strong buy to buy.
Shares of Zscaler (NASDAQ: ZS) have climbed nearly 10% so far this year, partly on the back of a strong financial report for ...
Navigating investments with tariffs requires a proactive approach. Here are risk management actions you can take today.
Cameco is a fantastic uranium miner that’s down around 30% from recent highs. If you’re still a believer in a nuclear-powered future, the dip looks like nothing more than an opportunity to buy.
Novo Nordisk shares rose Monday as the company said it would present new data on the ability of semaglutide, the active ingredient in its weight-loss drugs Ozempic and Wegovy, to lower heart risks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results